\u00c7ocukluk \u00e7a\u011f\u0131 kanserleri ile ilgili fark\u0131ndal\u0131k e\u011fitimleri olu\u015fturulabilece\u011fini ve kanseri i\u015faret eden belirtilerde hastalar\u0131n gerekli uzmanlara erken d\u00f6nemde y\u00f6nlendirilmesinin sa\u011flanabilece\u011fini ifade eden Medical Park Bah\u00e7elievler Hastanesi \u00c7ocuk Hematoloji\/ Onkoloji Uzman\u0131 Prof. Dr. Ceyhun Bozkurt, 15 \u015eubat Uluslararas\u0131 \u00c7ocukluk \u00c7a\u011f\u0131 Kanseri G\u00fcn\u00fc nedeniyle uyar\u0131larda bulundu<\/p>\n
NAD\u0130R DE OLSA SENDROM\u0130K HASTALIKLAR NEDEN OLAB\u0130L\u0130R<\/strong><\/p>\n \u00c7ocukluk \u00e7a\u011f\u0131 kanserlerinde y\u00fczde 90 oran\u0131nda kanserin neden olu\u015ftu\u011funun bilinmedi\u011fini s\u00f6yleyen Prof. Dr. Bozkurt, \u201cKalan y\u00fczde 10\u2019luk gruptaki \u00e7ocukluk \u00e7a\u011f\u0131 kanserleri ise baz\u0131 nadir g\u00f6r\u00fclen sendromik hastal\u0131\u011f\u0131 olan \u00e7ocuklarda, baz\u0131 immun yetmezlik hastal\u0131\u011f\u0131 olan \u00e7ocuklarda ve daha \u00f6nce kemoterapi ya da radyoterapi alm\u0131\u015f \u00e7ocuklarda g\u00f6r\u00fcl\u00fcr\u201d diye konu\u015ftu.<\/p>\n L\u00d6SEM\u0130 \u0130LK SIRADA YER ALIYOR<\/strong><\/p>\n Kanser hastal\u0131\u011f\u0131n\u0131n genelde geli\u015fmekte olan ve geli\u015fmi\u015f \u00fclkelerde 100 binde 400 dolay\u0131nda g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc dile getiren Prof. Dr. Bozkurt, \u201cT\u00fcm bu kanserlerin ise ancak y\u00fczde 1-2\u2019sini \u00e7ocukluk \u00e7a\u011f\u0131 kanserleri olu\u015fturur. Kabaca \u00e7ocukluk \u00e7a\u011f\u0131 kanserleri y\u00fcz binde 14-15 aras\u0131 oranlarda g\u00f6r\u00fcl\u00fcr. \u00dclkemiz kanser kay\u0131t sistemi verileri eski y\u0131llara oranla daha iyi bir oranda yap\u0131lmaktad\u0131r fakat kanser oranlar\u0131n\u0131n artt\u0131\u011f\u0131n\u0131 g\u00f6steren g\u00fcvenilir bir veri yoktur. \u00dclkemiz verilerine bakacak olursak en s\u0131k g\u00f6r\u00fclen \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinde ilk \u00fc\u00e7 s\u0131rada y\u00fczde 23 oran ile l\u00f6semiler, y\u00fczde 19 oran ile lenfomalar ve y\u00fczde 14 oran ile beyin ve omurilik t\u00fcm\u00f6rleri yer almaktad\u0131r\u201d \u015feklinde konu\u015ftu.<\/p>\n FARKLI KL\u0130N\u0130K BULGULAR G\u00d6R\u00dcLEB\u0130L\u0130R<\/strong><\/p>\n T\u00fcm kanser hastal\u0131klar\u0131nda oldu\u011fu gibi \u00e7ocukluk \u00e7a\u011f\u0131 kanser hastal\u0131klar\u0131nda da erken tan\u0131n\u0131n m\u00fcmk\u00fcn oldu\u011funa dikkat \u00e7eken Prof. Dr. Bozkurt, \u201c\u00c7ocuklarda farkl\u0131 klinik bulgular g\u00f6r\u00fclebilir. Bu konuda en b\u00fcy\u00fck g\u00f6rev \u00e7ocu\u011fu yak\u0131ndan takip eden anne-babalara, ard\u0131ndan da hekimlere d\u00fc\u015fmektedir\u201d ifadelerini kulland\u0131.<\/p>\n Prof. Dr. Bozkurt, Uluslararas\u0131 Kanser Kontrol Birli\u011fi (UICC)\u2019nin yapt\u0131\u011f\u0131 bir derlemeye g\u00f6re \u00e7ocuklu \u00e7a\u011f\u0131 kanserlerinde en s\u0131k g\u00f6r\u00fclen bulgular\u0131 \u015f\u00f6yle s\u0131ralad\u0131:<\/p>\n \u201cS\u0131ra d\u0131\u015f\u0131 kar\u0131n \u015fi\u015fli\u011fi ve kitlesi.<\/p>\n Uzun s\u00fcren ve a\u00e7\u0131klanamayan ate\u015f.<\/p>\n Solukluk, enerji kayb\u0131 ve h\u0131zl\u0131 kilo kayb\u0131.<\/p>\n A\u00e7\u0131klanamayan ve uzun s\u00fcren a\u011fr\u0131, s\u0131kl\u0131kla ba\u015f a\u011fr\u0131s\u0131 ile birlikte olan kusma.<\/p>\n Kolay olu\u015fan morluklar, a\u00e7\u0131klanamayan kanamalar.<\/p>\n Denge ve davran\u0131\u015fta ani de\u011fi\u015fiklikler.<\/p>\n G\u00f6z bebe\u011finde beyaz yans\u0131ma.<\/p>\n Ba\u015f b\u00fcy\u00fcmesi.\u201d<\/p>\n FARKLI TEDAV\u0130 SE\u00c7ENEKLER\u0130 UYGULANAB\u0130L\u0130R<\/strong><\/p>\n \u00c7ocukluk \u00e7a\u011f\u0131 kanser hastal\u0131\u011f\u0131n\u0131 iyile\u015ftirmek i\u00e7in t\u00fcm\u00f6r\u00fcn tipine g\u00f6re tedavi bi\u00e7iminin de\u011fi\u015febilece\u011fini ve s\u0131kl\u0131kla kemoterapi, cerrahi, radyoterapi ve k\u00f6k h\u00fccre nakli gibi tedavi se\u00e7eneklerinin kullan\u0131ld\u0131\u011f\u0131n\u0131 belirten Prof. Dr. Bozkurt, \u201cBunun yan\u0131nda radyoaktif ila\u00e7 ya da madde tedavileri, immunoterapi, hedefe y\u00f6nelik ila\u00e7 tedavileri, genetik yap\u0131s\u0131 de\u011fi\u015ftirilmi\u015f savunma h\u00fccre tedavileri, bireyselle\u015ftirilmi\u015f tedavi gibi tedavi y\u00f6ntemleri son y\u0131llarda giderek artan oranlarda kullan\u0131lan g\u00fcncel tedavi y\u00f6ntemleridir\u201d a\u00e7\u0131klamas\u0131nda bulundu.<\/p>\n Y\u00dcZ G\u00dcLD\u00dcR\u00dcC\u00dc SONU\u00c7LAR ELDE ED\u0130L\u0130YOR<\/strong><\/p>\n Y\u0131llar ge\u00e7tik\u00e7e \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinin tedavisinde ba\u015far\u0131 oranlar\u0131n\u0131n artt\u0131\u011f\u0131n\u0131 vurgulayan Prof. Dr. Bozkurt, \u015fu bilgileri payla\u015ft\u0131:<\/p>\n \u201c\u00c7ocukluk \u00e7a\u011f\u0131 kanserlerinde tedavi sonu\u00e7lar\u0131 olduk\u00e7a y\u00fcz g\u00fcld\u00fcr\u00fcc\u00fcd\u00fcr. T\u00fcm\u00f6r tipine, evresine, biyolojik ve genetik \u00f6zelliklerine g\u00f6re tedavi ba\u015far\u0131s\u0131 de\u011fi\u015fmekle birlikte genel olarak geli\u015fmi\u015f \u00fclkelerde t\u00fcm \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinin yakla\u015f\u0131k y\u00fczde 80\u2019i tamam\u0131yla iyile\u015febilmektedir. Bu oran baz\u0131 t\u00fcm\u00f6rlerde y\u00fczde 95 dolay\u0131ndad\u0131r. \u00dclkemizde de buna yak\u0131n oranlarda ba\u015far\u0131l\u0131 sonu\u00e7lar elde edilmektedir.\u201d<\/p>\n DOKTORA DANI\u015eMADAN HAREKET ED\u0130LMEMEL\u0130<\/strong><\/p>\n S\u0131kl\u0131kla olmasa da yap\u0131lan baz\u0131 hatalar\u0131n da alt\u0131n\u0131 \u00e7izen Prof. Dr. Bozkurt, \u201c\u00c7ocuk kanser hastalar\u0131n\u0131n tedavilerinin bu konuda deneyimli ve yetkili uzmanlar taraf\u0131ndan yap\u0131lmamas\u0131, ailelerin tedavileri aksatmalar\u0131 ya da b\u0131rakmalar\u0131, \u00e7a\u011fda\u015f, g\u00fcvenilir tedaviler yerine yarar\u0131 kan\u0131tlanmam\u0131\u015f uygulama, ila\u00e7 ya da birtak\u0131m maddelerin tedavi ama\u00e7l\u0131 aileler ya da yetkili olmayan ki\u015filerce denenmesi yap\u0131lan baz\u0131 hatalard\u0131r\u201d diye konu\u015ftu.<\/p>\n","protected":false},"excerpt":{"rendered":" T\u00fcm kanser hastal\u0131klar\u0131nda oldu\u011fu gibi \u00e7ocukluk \u00e7a\u011f\u0131 kanser hastal\u0131klar\u0131nda da erken tan\u0131n\u0131n m\u00fcmk\u00fcn oldu\u011funu belirten \u00c7ocuk Hematoloji\/ Onkoloji Uzman\u0131 Prof. Dr. Ceyhun Bozkurt, \u201c\u00c7ocuklarda uzun s\u00fcren ve a\u00e7\u0131klanamayan ate\u015f, h\u0131zl\u0131 kilo kayb\u0131, v\u00fccutta kolay olu\u015fan morluklar, a\u00e7\u0131klanamayan kanamalar, s\u0131ra d\u0131\u015f\u0131 kar\u0131n \u015fi\u015fli\u011fi veya kitlesi, solukluk, enerji kayb\u0131, a\u00e7\u0131klanamayan ve uzun s\u00fcren a\u011fr\u0131, s\u0131kl\u0131kla ba\u015f a\u011fr\u0131s\u0131 ile birlikte olan kusma, denge ve davran\u0131\u015fta ani de\u011fi\u015fiklikler, g\u00f6z bebe\u011finde beyaz yans\u0131ma veya ba\u015f b\u00fcy\u00fcmesi \u00e7ocukluk \u00e7a\u011f\u0131 kanserlerinin belirtilerinden olabilir. Bu konuda en b\u00fcy\u00fck g\u00f6rev \u00e7ocu\u011fu yak\u0131ndan takip eden anne-babalara, ard\u0131ndan da hekimlere d\u00fc\u015fmektedir\u201d dedi.<\/p>\n","protected":false},"author":6,"featured_media":10478,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[53],"tags":[189,527,2420,87],"class_list":["post-10476","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-cocuk","tag-kanser","tag-prof-dr-ceyhun-bozkurt","tag-saglik"],"_links":{"self":[{"href":"https:\/\/www.ihm.tr\/tr-int\/wp-json\/wp\/v2\/posts\/10476","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ihm.tr\/tr-int\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ihm.tr\/tr-int\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ihm.tr\/tr-int\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ihm.tr\/tr-int\/wp-json\/wp\/v2\/comments?post=10476"}],"version-history":[{"count":1,"href":"https:\/\/www.ihm.tr\/tr-int\/wp-json\/wp\/v2\/posts\/10476\/revisions"}],"predecessor-version":[{"id":10479,"href":"https:\/\/www.ihm.tr\/tr-int\/wp-json\/wp\/v2\/posts\/10476\/revisions\/10479"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ihm.tr\/tr-int\/wp-json\/wp\/v2\/media\/10478"}],"wp:attachment":[{"href":"https:\/\/www.ihm.tr\/tr-int\/wp-json\/wp\/v2\/media?parent=10476"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ihm.tr\/tr-int\/wp-json\/wp\/v2\/categories?post=10476"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ihm.tr\/tr-int\/wp-json\/wp\/v2\/tags?post=10476"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}